161 related articles for article (PubMed ID: 17304154)
1. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
Böhler T; Nolting J; Kamar N; Gurragchaa P; Reisener K; Glander P; Neumayer HH; Budde K; Klupp J
Ther Drug Monit; 2007 Feb; 29(1):77-86. PubMed ID: 17304154
[TBL] [Abstract][Full Text] [Related]
2. Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patients.
Böhler T; Canivet C; Nguyen PN; Galvani S; Thomsen M; Durand D; Salvayre R; Negre-Salvayre A; Rostaing L; Kamar N
Cytokine; 2009 Mar; 45(3):169-73. PubMed ID: 19147373
[TBL] [Abstract][Full Text] [Related]
3. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
[TBL] [Abstract][Full Text] [Related]
4. The influence of cyclosporin A on lymphocyte attenuator expression.
Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
[TBL] [Abstract][Full Text] [Related]
5. Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells.
Brandt C; Liman P; Bendfeldt H; Mueller K; Reinke P; Radbruch A; Worm M; Baumgrass R
Cytometry A; 2010 Jul; 77(7):607-13. PubMed ID: 20583270
[TBL] [Abstract][Full Text] [Related]
6. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
[TBL] [Abstract][Full Text] [Related]
8. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ
Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
Barten MJ; Gummert JF; van Gelder T; Shorthouse R; Morris RE
J Immunol Methods; 2001 Jul; 253(1-2):95-112. PubMed ID: 11384672
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
[TBL] [Abstract][Full Text] [Related]
11. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes.
Weaver JL; Pine PS; Aszalos A
Immunopharmacol Immunotoxicol; 1991; 13(4):563-76. PubMed ID: 1723084
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy.
Stalder M; Bîrsan T; Hausen B; Borie DC; Morris RE
Transpl Int; 2005 Oct; 18(10):1158-65. PubMed ID: 16162103
[TBL] [Abstract][Full Text] [Related]
14. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
Degiannis D; Koniavitou K
Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
[No Abstract] [Full Text] [Related]
15. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.
Hirano T; Fukushima H; Sasaki Y; Yoshikawa N; Yoshida M; Oka K
Int Immunopharmacol; 2006 Jun; 6(6):924-34. PubMed ID: 16644478
[TBL] [Abstract][Full Text] [Related]
16. Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Samaniego MD; Choi MJ; Burdick JF
Cytokine; 1997 Aug; 9(8):624-8. PubMed ID: 9245491
[TBL] [Abstract][Full Text] [Related]
17. Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
Kovarik JM; Stitah S; Slade A; Vitaliti A; Straube F; Grenet O; Winter S; Sfikas N; Seiberling M
J Clin Pharmacol; 2010 Nov; 50(11):1260-6. PubMed ID: 20386017
[TBL] [Abstract][Full Text] [Related]
18. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
[TBL] [Abstract][Full Text] [Related]
19. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
[TBL] [Abstract][Full Text] [Related]
20. Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation.
Böhler T; Nolting J; Gurragchaa P; Lupescu A; Neumayer HH; Budde K; Kamar N; Klupp J
Transpl Immunol; 2008 Feb; 18(4):319-23. PubMed ID: 18158117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
